Task: Answer the multiple choice question.
Query: Which compound exhibits a 3.045\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC1Oc2ccccc2N(CC(=O)N2CCCC2)C1=O
b COc1cccc(N(CC(=O)NC2CCCCC2)C(=O)c2snc(C(N)=O)c2N)c1
c C=CCN1C(=O)C(=O)N(CC(=O)c2ccc3c(c2)CCCC3)C1=O
Answer: c. C=CCN1C(=O)C(=O)N(CC(=O)c2ccc3c(c2)CCCC3)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCN1C(=O)C(=O)N(CC(=O)c2ccc3c(c2)CCCC3)C1=O
C=CCN1C(=O)C(=O)N(CC(=O)c2ccc3c(c2)CCCC3)C1=O
1-[2-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]-3-prop-2-enylimidazolidine-2,4,5-trione